Acute Pancreatitis Market Research Report - Global Forecast till 2027

Acute Pancreatitis Market: Information by Cause (Gallstones, Alcohol and Other Causes), by Treatment & Diagnosis (Treatment [Intravenous Fluid, Analgesics, Nutritional Support, Endoscopic Retrograde Cholangiopancreatography (ERCP) and Others] and Diagnosis[Imaging Tests, Laboratory Tests]), By End User (Hospitals & Clinics and Others) and by Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/1036-CR | December 2019 | Region: Global | 118 Pages         

Acute Pancreatitis Market Speak to Analyst Request a Free Sample

Acute Pancreatitis Market Overview


Based on researches, Acute Pancreatitis Market is expected to grow at a CAGR of 5.91% during the forecast period. In 2025, the acute pancreatitis market size is expected be USD 7372.01 million.


The acute pancreatitis pain causes because of the inflammatory situation in the pancreas. Most of the common acute pancreatitis causes are the gastrointestinal causes. This is a very painful situation and can become dangerous as well. The annual rate of pancreas cases are 4.9 to 73 per 100,000 people across the globe, based on the reports of NCBI. In fact, the mortality rate of acute pancreatitis is more or less 10%.


The rising prevalence of gastrointestinal problems are the major driving force behind the growth of the market. On the other hand, some strict regulations from FDA can become a challenging factor for the growth of the market.


Covid-19 impact


The covid-19 pandemic has taken a toll over industries. The healthcare sectors have been highly impacted by this. The acute pancreatitis management was impacted by the lockdown situation. The situation had gone worse because of the lockdown. The problems were highly increased and proper aid was not available because of sudden lockdown decisions taken by the governing bodies. As the situation is turning towards normalcy, the acute pancreatitis diagnosis and medication for acute pancreatitis are becoming available once again.


Market dynamics


The acute pancreatitis pain management is mostly dependant on the complexity of the disease. The acute pancreatitis treatment includes pain medication, hydration therapy, nutritional support, pancreatic enzymes such as Somatostatin and Antibiotics. Surgery has zero to little effect on the problem.


Drivers


There are various reasons behind the growth of the acute pancreatitis market. People these days are enjoying a reckless lifestyle, which is one of the biggest reasons behind the rising rate of the disease. However, there are other reasons as well. For example, the increasing prevalence of gallstones, heavy consumption of alcohol, poor food habits are some of the other reasons too. Apart from that, the increasing rate of investments, as well as advanced treatment procedures, are some of the reasons behind the rising growth of the acute pancreatitis market.


Technological analysis


This is an acute inflammatory disease that happens in the pancreas, which is present in the upper abdominal area. Some of the common symptoms of the disease include nausea, vomiting. There are various reasons behind the cause of acute pancreatitis. One of the common reasons is inflammation that leads to pancreatic cell death along with systematic inflammation. As a result, it often leads to organ failure. The rate of acute pancreatitis is gradually rising; as a result, the demand for the treatments is automatically rising. In most cases, the pain begins in the upper abdomen and becomes too much to tolerate.


Segmentation overview


The Acute Pancreatitis Global Market is segmented into-



  • Cause

  • Treatment

  • Diagnosis

  • End-user

  • Region


By Cause


Based on cause, the Acute Pancreatitis Market is further segmented into-



  • Gallstones

  • Alcohol

  • Others


By Treatment


Based on cause, the Acute Pancreatitis Market is further segmented into-



  • Intravenous fluid

  • Nutritional support

  • Analgesics

  • Endoscopic retrograde cholangiopancreatography (ERCP)

  • Others


By Diagnosis


Based on cause, the Acute Pancreatitis Market is further segmented into-



  • Imaging tests

  • Laboratory tests


By End-user


Based on cause, the Acute Pancreatitis Global Market is further segmented into-



  • Hospitals

  • Clinics

  • Others


By Region


Based on cause, the Acute Pancreatitis Market is further segmented into-



  • Americas

  • US

  • Canada

  • Europe

  • Germany

  • France

  • The UK

  • Italy

  • Spain

  • Rest of the Europe

  • Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Rest of Asia-Pacific

  • The MEA

  • Middle East

  • Africa


Regional analysis


The market is broadly divided into Americas, Europe, Asia-Pacific and the MEA. The increasing cases of acute pancreatitis are increasing throughout the world. However, there are few regions that are worst hit due to the poor lifestyle choices made by the people. Market segmentation can be done depending on some of the significant factors. Nevertheless, the regions that hold the maximum share of the acute pancreatitis market include North America, followed by Europe, and the Asia Pacific region. Depending on the severity of the conditions, the markets are growing here.


Competitive landscape


 Major key players in the market are investing in R&Ds, merger and acquisitions, colaborating with each other. They are focusing more on new product launches and product development. There are many major key players contributing highly in the growth of the acute pancreatitis market but some of the top players that are involved in the global market include SCM Lifescience, General Electric Company, CalciMedica, B. Braun Melsungen AG, Samsung Bioepis, Boston Scientific Corporation, Baxter International Inc., Fresenius Kabi USA, etc. These are some of the top players in the market that are handling the Global Acute Pancreatitis Market efficiently.


Major key players



  • CalciMedica

  • SCM Lifescience

  • Samsung Bioepis

  • GNT Pharma Co.

  • Baxter International Inc.

  • Braun Melsungen AG

  • General Electric Company

  • Medtronic

  • Boston Scientific Corporation

  • and Fresenius Kabi USA.


Report Overview


The report comprises of               



  • Market overview

  • Covid-19 impact

  • Market dynamics

  • Drivers

  • Challenges

  • Restrains

  • Opportunities

  • Technological analysis

  • Segmentation overview

  • Regional analysis

  • Competitive landscape

  • Recent developments

  • Major key players


 



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Acute Pancreatitis Market is projected to grow at approximately 5.91% CAGR during the assessment period (2019-2025).

Acute Pancreatitis Market is estimated to reach a valuation of approx. USD 7372.01 MN by the end of 2025.

Rising prevalence of gallstones, high consumption of alcohol, and increasing investments and advancements in treatment procedures, are major tailwinds pushing the growth of the Global Acute Pancreatitis Market.

North America holds the largest share in the Global Acute Pancreatitis Market, followed by Europe and the Asia Pacific, respectively.

SCM Lifescience, General Electric Company, CalciMedica, B. Braun Melsungen AG, Samsung Bioepis, Medtronic, Boston Scientific Corporation, Baxter International Inc., Fresenius Kabi USA, and GNT Pharma Co., are some of the top players operating in the Global Acute Pancreatitis Market.